Lei Gu - Publications

Affiliations: 
2014- Harvard Medical School - Boston Children's Hospital 

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Chu Z, Gu L, Hu Y, Zhang X, Li M, Chen J, Teng D, Huang M, Shen CH, Cai L, Yoshida T, Qi Y, Niu Z, Feng A, Geng S, et al. STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming. Nature Communications. 13: 1859. PMID 35388001 DOI: 10.1038/s41467-022-29541-9  0.382
2021 Blanco MA, Sykes DB, Gu L, Wu M, Petroni R, Karnik R, Wawer M, Rico J, Li H, Jacobus WD, Jambhekar A, Cheloufi S, Meissner A, Hochedlinger K, Scadden DT, et al. Chromatin-state barriers enforce an irreversible mammalian cell fate decision. Cell Reports. 37: 109967. PMID 34758323 DOI: 10.1016/j.celrep.2021.109967  0.32
2020 Gu L, Wang L, Chen H, Hong J, Shen Z, Dhall A, Lao T, Liu C, Wang Z, Xu Y, Tang HW, Chakraborty D, Chen J, Liu Z, Rogulja D, et al. CG14906 (mettl4) mediates mA methylation of U2 snRNA in Drosophila. Cell Discovery. 6: 44. PMID 34188020 DOI: 10.1038/s41421-020-0178-7  0.71
2020 Gu L, Wang L, Chen H, Hong J, Shen Z, Dhall A, Lao T, Liu C, Wang Z, Xu Y, Tang HW, Chakraborty D, Chen J, Liu Z, Rogulja D, et al. CG14906 (mettl4) mediates mA methylation of U2 snRNA in . Cell Discovery. 6: 44. PMID 32637152 DOI: 10.1038/S41421-020-0178-7  0.699
2020 Chen H, Gu L, Orellana EA, Wang Y, Guo J, Liu Q, Wang L, Shen Z, Wu H, Gregory RI, Xing Y, Shi Y. METTL4 is an snRNA mAm methyltransferase that regulates RNA splicing. Cell Research. PMID 31913360 DOI: 10.1038/S41422-019-0270-4  0.375
2019 Goeppert B, Toth R, Singer S, Albrecht T, Lipka DB, Lutsik P, Brocks D, Baehr M, Muecke O, Assenov Y, Gu L, Endris V, Stenzinger A, Mehrabi A, Schirmacher P, et al. Integrative analysis defines distinct prognostic subgroups of intrahepatic cholangiocarcinoma. Hepatology (Baltimore, Md.). PMID 30615206 DOI: 10.1002/Hep.30493  0.334
2016 Trump S, Bieg M, Gu Z, Thürmann L, Bauer T, Bauer M, Ishaque N, Röder S, Gu L, Herberth G, Lawerenz C, Borte M, Schlesner M, Plass C, Diessl N, et al. Prenatal maternal stress and wheeze in children: novel insights into epigenetic regulation. Scientific Reports. 6: 28616. PMID 27349968 DOI: 10.1038/Srep28616  0.301
2016 Shen H, Xu W, Guo R, Rong B, Gu L, Wang Z, He C, Zheng L, Hu X, Hu Z, Shao ZM, Yang P, Wu F, Shi YG, Shi Y, et al. Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex. Cell. 165: 331-342. PMID 27058665 DOI: 10.1016/J.Cell.2016.02.064  0.472
2016 Bauer T, Trump S, Ishaque N, Thürmann L, Gu L, Bauer M, Bieg M, Gu Z, Weichenhan D, Mallm JP, Röder S, Herberth G, Takada E, Mücke O, Winter M, et al. Environment-induced epigenetic reprogramming in genomic regulatory elements in smoking mothers and their children. Molecular Systems Biology. 12: 861. PMID 27013061 DOI: 10.15252/Msb.20156520  0.389
2016 Iwase S, Brookes E, Agarwal S, Badeaux AI, Ito H, Vallianatos CN, Tomassy GS, Kasza T, Lin G, Thompson A, Gu L, Kwan KY, Chen C, Sartor MA, Egan B, et al. A Mouse Model of X-linked Intellectual Disability Associated with Impaired Removal of Histone Methylation. Cell Reports. PMID 26804915 DOI: 10.1016/J.Celrep.2015.12.091  0.463
2016 Oakes CC, Seifert M, Assenov Y, Gu L, Przekopowitz M, Ruppert AS, Wang Q, Imbusch CD, Serva A, Koser SD, Brocks D, Lipka DB, Bogatyrova O, Weichenhan D, Brors B, et al. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia. Nature Genetics. PMID 26780610 DOI: 10.1038/Ng.3488  0.333
2015 Greer EL, Blanco MA, Gu L, Sendinc E, Liu J, Aristizábal-Corrales D, Hsu CH, Aravind L, He C, Shi Y. DNA Methylation on N(6)-Adenine in C. elegans. Cell. 161: 868-78. PMID 25936839 DOI: 10.1016/J.Cell.2015.04.005  0.708
2015 Gu L, Frommel SC, Oakes CC, Simon R, Grupp K, Gerig CY, Bär D, Robinson MD, Baer C, Weiss M, Gu Z, Schapira M, Kuner R, Sültmann H, Provenzano M, et al. BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence. Nature Genetics. 47: 22-30. PMID 25485837 DOI: 10.1038/Ng.3165  0.345
2015 Oakes CC, Seifert M, Assenov Y, Gu L, Przekopowitz M, Ruppert AS, Wang Q, Imbusch C, Serva A, Koser S, Brocks D, Lipka DB, Bogatyrova O, Brors B, Weichenhan D, et al. Progressive Epigenetic Programming during B Cell Maturation Is Reflected in a Continuum of Epigenetic Disease Phenotypes in Chronic Lymphocytic Leukemia Blood. 126: 2436-2436. DOI: 10.1182/Blood.V126.23.2436.2436  0.349
2015 Lipka DB, Witte T, Wiesenfarth M, Zucknick M, Konermann C, Gu L, Claus R, Nöllke P, Niemeyer C, Flotho C, Plass C. Genome-wide DNA methylation profiling reveals two prognostically distinct subgroups of juvenile myelomonocytic leukemia Experimental Hematology. 43: S47. DOI: 10.1016/J.Exphem.2015.06.059  0.365
2014 Lipka DB, Wang Q, Cabezas-Wallscheid N, Klimmeck D, Weichenhan D, Herrmann C, Lier A, Brocks D, von Paleske L, Renders S, Wünsche P, Zeisberger P, Gu L, Haas S, Essers MA, et al. Identification of DNA methylation changes at cis-regulatory elements during early steps of HSC differentiation using tagmentation-based whole genome bisulfite sequencing. Cell Cycle (Georgetown, Tex.). 13: 3476-87. PMID 25483069 DOI: 10.4161/15384101.2014.973334  0.386
2014 Sonnet M, Claus R, Becker N, Zucknick M, Petersen J, Lipka DB, Oakes CC, Andrulis M, Lier A, Milsom MD, Witte T, Gu L, Kim-Wanner SZ, Schirmacher P, Wulfert M, et al. Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia. Genome Medicine. 6: 34. PMID 24944583 DOI: 10.1186/Gm551  0.368
2014 Oakes CC, Claus R, Gu L, Assenov Y, Hüllein J, Zucknick M, Bieg M, Brocks D, Bogatyrova O, Schmidt CR, Rassenti L, Kipps TJ, Mertens D, Lichter P, Döhner H, et al. Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia. Cancer Discovery. 4: 348-61. PMID 24356097 DOI: 10.1158/2159-8290.Cd-13-0349  0.388
2013 Wang Q, Gu L, Adey A, Radlwimmer B, Wang W, Hovestadt V, Bähr M, Wolf S, Shendure J, Eils R, Plass C, Weichenhan D. Tagmentation-based whole-genome bisulfite sequencing. Nature Protocols. 8: 2022-32. PMID 24071908 DOI: 10.1038/Nprot.2013.118  0.344
2013 Scherf DB, Sarkisyan N, Jacobsson H, Claus R, Bermejo JL, Peil B, Gu L, Muley T, Meister M, Dienemann H, Plass C, Risch A. Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4. Oncogene. 32: 3329-38. PMID 22945651 DOI: 10.1038/Onc.2012.344  0.355
2013 Oakes CC, Claus R, Gu L, Assenov Y, Hüllein J, Zucknick M, Brocks D, Bogatyrova O, Schmidt CR, Rassenti L, Kipps TJ, Mertens D, Lichter P, Döhner H, Stilgenbauer S, et al. Heterogeneity and Evolution Of DNA Methylation In Chronic Lymphocytic Leukemia Blood. 122: 1626-1626. DOI: 10.1182/Blood.V122.21.1626.1626  0.4
2012 Baer C, Claus R, Frenzel LP, Zucknick M, Park YJ, Gu L, Weichenhan D, Fischer M, Pallasch CP, Herpel E, Rehli M, Byrd JC, Wendtner CM, Plass C. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. Cancer Research. 72: 3775-85. PMID 22710432 DOI: 10.1158/0008-5472.Can-12-0803  0.33
2012 Baer C, Rehli M, Byrd JC, Wendtner C, Plass C, Claus R, Frenzel L, Zucknick M, Park YJ, Gu L, Weichenhan D, Fischer M, Pallasch C. Abstract B10: Genome-wide profiling reveals hyper- and hypomethylation at microRNA promoters in chronic lymphocytic leukemia Cancer Research. 72: B10-B10. DOI: 10.1158/1538-7445.Nonrna12-B10  0.322
Show low-probability matches.